News releases Back to the news list January 29, 2010 Æterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom’s Macroglobulinemia Please see PDF file attached.

Term and conditions of use. Safe harbor and privacy policy. Copyright © 2004 Æterna Zentaris Inc. All rights reserved. Use of this site signifies your agreement to the terms of use.